MDMatthew D’MEllow

Matthew D’MEllow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthew D’MEllow has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phenotypic and Genotypic Risk Factors for Uveal Melanoma in a High Ambient UV Radiation Environment

    by Jane M. Palmer, Catherine M. Olsen, Matthew D’MEllow, Lindsay A. McGrath, Sunil K. Warrier, William J. Glasson, Timothy Beckman, Huanwei Wang, Nirmala Pandeya, Matthew H. Law, et al.

    Background: Most evidence on risk factors for uveal melanoma derives from case–control studies prone to recall bias, and its rarity has limited prospective research. To address these gaps, we applied a population-based case–control design incorporating polygenic risk scores (PRS) and Mendelian randomization (MR) to explore genetic and phenotypic determinants of uveal melanoma risk. Methods: The study was conducted in Queensland, Australia. Incident uveal melanoma cases diagnosed between 2011 and 2022 were recruited through specialist ocular oncology clinics. Controls were participants in the QSkin Sun and Health Study, a prospective cohort of 43,794 adults 40 to 69 years of age at baseline (2010–2011). Demographic, phenotypic, and sun exposure factors were harmonized across studies. PRSs were calculated for pigmentation traits and nevus characteristics using genome-wide association study (GWAS) datasets, and MR was used to assess potential causal relationships with uveal melanoma risk. Results: Among 485 uveal melanoma cases and 43,724 controls, several phenotypic traits were strongly associated with uveal melanoma risk: male sex, blue or light eye color, inability to tan, freckling, and high nevus density. A family history of cutaneous melanoma and a personal history of keratinocyte cancer were also associated with higher risk. PRS analyses confirmed significant associations for eye color and freckling. MR analyses supported causal relationships between lighter eye color, freckling propensity, and reduced tanning ability and uveal melanoma risk. Conclusions: These findings provide genetic evidence supporting a causal role for pigmentation-related traits in uveal melanoma susceptibility. Impact: This evidence may help refine risk assessment and inform counseling for individuals with suspicious ocular lesions.

  • Open Access

    GWAS meta-analysis provides new insights into uveal melanoma risk

    by Matthew D’MEllow, Huanwei Wang, Jane M. Palmer, Kari Hemminki, Colleen M. Cebulla, Aaron B. Beasley, Nikolaos E. Bechrakis, Antonia L. Pritchard, Karin W. Wadt, Peter A. Johansson, et al.

    Objective: The aim of this research is to identify germline genetic variants that predispose to uveal melanoma (UM) using data from nine studies involving 5839 individuals with UM (3853 novel) and 349,863 healthy controls. Methods: Five novel UM genome-wide association studies (GWAS) were performed and included for meta-analysis with four previously published UM GWAS. A fixed-effects inverse-variance weighted (IVW) meta-analysis was performed by combining data from these nine UM case-control cohorts. A follow-up transcriptome-wide association study (TWAS) was conducted to identify candidate target genes at UM risk loci. Genetic correlations with melanoma-related phenotypes were measured to elucidate UM’s genetic architecture. Results: We identify nine linkage disequilibrium (LD)-independent loci (three novel) with an IVW P value of less than 5 × 10 −8 . TWAS analysis indicates five potential target genes, including MOB3B , RBAK , and MTSS1 , which have established links to multiple cancer types. We note a significant genetic correlation (rg = 0.31, P = 0.01) between UM and cutaneous melanoma (CM), and a non-significant but consistent correlation with naevus count (rg = 0.25, P = 0.08). Conclusions: This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.